Pertussis. Faculty/Presenter Disclosure. Disclosure of Commercial Support. Mitigating Potential Bias. True Case 07/10/2013 DISCLOSURE
|
|
- Simon Nash
- 5 years ago
- Views:
Transcription
1 Pertussis Outbreaks first described in the 16th Century Major cause of childhood fatality prior to vaccination Alan Kaplan Chair, Respiratory Medicine Group of College of Family Physicians of Canada Thanks to Dr.Anthony Ciavarella for assistance in formatting these slides DISCLOSURE Dr. Alan G. Kaplan Chair, Family Physician Airways Group of Canada Perceive no conflict of interest with giving this presentation, ti but present the following companies that I have worked with or consulted for: Astra Zeneca, Bayer, Boehringer Ingeleheim, Graceway, GSK, JOI, Merck Frosst, Novartis, Nycomed, Pfizer, Purdue, and Talecris,. In addition, I am on Health Canada committee for Section of Allergy and Respiratory Therapeutics and Public Health Agency of Canada Section of Respiratory Surveillance CFPC CoI Templates: Slide 1 Faculty/Presenter Disclosure Faculty: Alan Kaplan MD CCFP(EM) FCFP Chair Family Physician Airways Group of Canada Chair of Special Interest Focused Practice, College of Family Physicians in Respiratory Medicine. Relationships with commercial interests: Grants/Research Support: none Speakers Bureau/Honoraria: Astra Zeneca, Boehringer Ingelheim, Griffols, Pfizer, Purdue, Merck Frosst, Novartis, sanofi, Takeda. Consulting Fees: Aerocrine, Novartis, Takeda, Purdue, Pfizer Other: Member of Health Canada Section on Allergy and Respiratory Therapeutics. Member of Public Health Agency of Canada section on Respiratory Surveillance CFPC CoI Templates: Slide 2 Disclosure of Commercial Support This program has received financial support from [none]. This program has received in kind support from none in the form of. Potential for conflict(s) of interest: Alan Kaplan has received [consultancy fees, speakers fees or been involved in research ] from A) there are no organizations supporting this program B) The following companies make respiratory products that I may mention in this talk including: Aerocrine, Astra Zeneca, Boehringer Ingelheim, Griffols, GSK, Merck Frosst, Pfizer, Purdue, Novartis, Sanofi, Takeda, There are no organizations supporting a product that will be discussed in this program. CFPC CoI Templates: Slide 3 Mitigating Potential Bias I will mitigate any bias by discussing appropriately all treatement and diagnostic options for respiratory care in my talk today True Case 13 year old girl with a cough for three days In cabin at camp with 20 other girls her age Wakes her at night No history of asthma or lung problems Had her boosters at 6 years old What should you consider? 6 1
2 Pertussis A great imitator in early stages How do you diagnose pertussis? What are the complications of it? How can we prevent it? Pertussis: Bordetella Pertussis Highly Contagious Respiratory Infection Respiratory Tract Lumen Normal Ciliary Movement Ciliary Stasis Ciliated Respiratory Epithelial Cells Pertussis Toxin B. Pertussis Bacterium Filamentous Hemagglutinin 7 Catarrhal: Mild cough Runny nose Mild fever Apnea in infants Catarrhal Pertussis: Clinical Phases Typical Course of Pertussis* Paroxysmal Cough Cough Paroxysmal Cough Whooping Vomiting Cyanosis Apnea Paroxysmal Cough 1 6 weeks accessed October 05, 2013 Convalescent: Cough less paroxysmal disappears in weeks *The illness can be milder and the typical "whoop" absent in children, teens, and adults who have been vaccinated with a pertussis vaccine. Convalescence Pertussis: Contagious* Period Pertussis is most contagious during the first 2 weeks when symptoms resemble those of a common cold. Contagiousness declines rapidly after that, t but may last up to three weeks. Patients are no longer infectious after 5 days of treatment with appropriate antibiotics. *Older persons often source of infection for children. most contagious aspc.gc.ca/id mi/pertussis coqueluche eng.php 2013 October 02 Pertussis:Diagnosis The diagnosis of pertussis is based on a characteristic clinical history: cough for more than 2 weeks with whoop, paroxysms, or post tussive vomiting And a variety it of lb laboratory tests: t culture polymerase chain reaction [PCR] direct fluorescent antibody [DFA] serology. Paroxysmal Cough > 2 weeks Pertussis: Nasopharyngeal Swab* posterior nasopharynx not the throat Dacron or calcium alginate plated directly on selective media. not cotton *Isolation rates are highest during the first 3 to 4 weeks of illness (catarrhal and early paroxysmal stages). isolation rates are highest 2
3 Pertussis: Complications Youth Major* Complications Infants & Young Children Hypoxia Apnea Secondary Pneumonia Seizures Encephalopathy Death** *Major complications are most common among infants and young children. ** Most deaths occur among unvaccinated children or children too young to be vaccinated Paroxysmal Cough Phase Pertussis: Complications Adults B. Pertussis Bacterium Pertussis Toxin Filamentous Hemagglutinin Major* Complications Adults Pneumonia Rib Fracture Loss of consciousness Hernias Urinary Incontinence Weight Loss ** In older children and adults, the disease is less serious and complications are rare. Paroxysmal Cough Phase nt Percen 70% 60% 50% Pertussis: Complications* by Age *Most complications occur in children <12 months of age, especially those <6 months. 40% 30% 20% 10% 0% Pneumonia Hospitalization Condition % Reported Pneumonia 5.2% Seizures 0.8% Encephalopathy 0.1% Hospitalization 20.0% Death 0.2% <6 m 6 11 m 1 4 y 5 9 y y 20+ y Age group Pertussis:Treatment Antibiotic Therapy Erythromycin Azithromycin Clarithromycin Trimethoprim sulfamethoxazole Maintaining high vaccination coverage rates among preschool children, adolescents, and adults and minimizing exposures of infants and persons at high risk for pertussis is the most effective way to prevent pertussis. ; Cases reported to CDC (N=28, 187) Centers for Disease Control and Prevention; 1600 Clifton Rd; Atlanta, GA accessed 2013 October accessed 2013 October03 Pertussis: Prevention A. Vaccination: Children < 6 years need 5 doses of the Pertussis vaccine, starting at age 2 months An additional booster dose, combined with tetanus and diphtheria (Tdap) vaccine, is given routinely to adolescents between 14 to 16 years of age across Canada. Adults not previously immunized against pertussis receive 1dose of the Tdap vaccine B. Clinical Assessment: anyone with a cough that lasts longer than a week should see your health care provider. C. Proper hand washing. Fully Immunize Adults & Children Public Health Agency of Canada; home > Infectious Diseases > Pertussis (Whooping Cough) Fact Sheet aspc.gc.ca/id mi/pertussis coqueluche eng.php accessed 06 October 2013 Pertussis containing Vaccines Pertussis vaccine is only available as an acellular preparation in a combination vaccine A. ap Petussis full antigen dose Pediatric formulation uato children < 7 years of age (DTaP HB IPV Hib); (DTaP IPV Hib); (DTaP IPV) B. ap * Petussis reduced antigen dose adolescent/adult formulation Tdap*; Tdap IPV* 10 to 18 years [Boostrix]; 11 to 64 years (Adacel *may be administered as a booster dose to children 4 to 7 years of age 3
4 Canada: Authorized Preparations A. ap Petussis full antigen dose: DTaP HB IPV Hib: INFANRIX hexa DTaP IPV Hib: PEDIACEL DTaP IPV: QUADRACEL Pertussis Vaccination Programs Work Pertussis Reported Incidence in Canada B. ap Petussis reduced antigen dose: Tdap: ADACEL ; BOOSTRIX : Tdap IPV: ADACEL POLIO; BOOSTRIX POLIO Pertussis Containing Vaccines Storage and Handling: Stored at F (2 8 C) at all times; Must never be frozen Vaccine exposed to freezing temperature must not be administered and should be discarded Do not be used after the expiration date printed on the box or label aspc.gc.ca/publicat/cig gci/index eng.php accessed 06 October 2013 Case data obtained from the Canadian Notifiable Disease Surveillance System. Population data obtained from Statistics Canada July 1 st annual estimates. Pertussis Vaccinations need re working Pertussis incidence in adolescents/ adults by age &year Infants & children (2 months to 6 years): A typical vaccination program for baby born on: 06 October 2013 in British Columbia CANADA DTaP HB IPV Hib: Hib: DTaP IPV Hib: DTaP IPV: 2, 4, 6 months of age 18 months of age 4 to 6 years of age 1980 year 2010 *Case data obtained from the Canadian Notifiable Disease Surveillance System. Data for 2009 and 2010 are preliminary. Population data obtained from Statistics Canada July 1 st annual estimates. Public Health Agency of Canada: Home > Immunization & Vaccines > Immunize your Child > Your immunization schedule > Immunization Results aspc.gc.ca/im/iyc vve/immunizationresults eng.php?p%2ft=2&months=10&days=6&years=2013#scheduler frm Adolescents A typical vaccination program for Adolescents in British Columbia CANADA Tdap*: Grade 9 (or between years old). * Should be received 10 years after 4 6 year old DTaP IPV booster dose. Tetanus vaccine (Td) should then follow Tdap every 10 years thereafter. Adults 19 Through 64 Years of Age Adults who have not previously received Tdap vaccine in adulthood should receive 1 dose of Tdap vaccine. Tdap can be administered regardless of the interval since the last dose of tetanus and diphtheria toxoid containing vaccine Public Health Agency of Canada: Home > Immunization & Vaccines > Immunize your Child > Your immunization schedule > Immunization Results aspc.gc.ca/im/iyc vve/immunizationresults eng.php?p%2ft=2&months=10&days=6&years=2013#scheduler frm 4
5 Healthcare Personnel & Child Care Workers All health care and child care workers, regardless of age, should receive: a single dose of Tdap vaccine if not previously received in adulthood, even if not due for a Td booster. Pertussis Immunization Contraindications: anaphylaxis Pertussis containing vaccines are contraindicated in persons with a history of anaphylaxis after previous administration of the vaccine and in persons with proven immediate or anaphylactic hl hypersensitivity i i to any component* of the vaccine or its container *ADACEL POLIO: neomycin, polymyxin B, streptomycin BOOSTRIX : latex in plunger stopper of pre filled syringe BOOSTRIX POLIO: latex in plunger stopper of pre filled syringe, neomycin, polymyxin B INFANRIX hexa : latex in plunger stopper of pre filled syringe, neomycin, polymyxin B, yeast PEDIACEL : neomycin, polymyxin B, streptomycin QUADRACEL : neomycin, polymyxin B There are no currently known potential allergens in ADACEL vaccine. Hypersensitivity to yeast is very rare and a personal history of yeast allergy is not generally reliable. Pertussis Immunization Contraindications: Guillain Barre Syndrome* It is prudent to not administer further doses of tetanustoxoid containing vaccine to persons who develop Guillain Barre Syndrome* (GBS) within 6 weeks of receiving such vaccine. Those who develop GBS outside the 6 week interval may receive subsequent doses of tetanus toxoid containing vaccine. *If there is a history of both Campylobacter infection (which has been associated with GBS) and receipt of a tetanus and diphtheria toxoid containing vaccine within the 6 weeks before the onset of GBS, consultation with an infectious disease specialist is advised. Pertussis Immunization: Precautions severe acute illness Administration of pertussis containing vaccine should be postponed in persons with moderate or severe acute illness. Persons with minor acute illness (with or without fever) may be vaccinated. Pertussis Immunization: Common and local adverse events Redness, swelling and pain at the injection site are the most common adverse reactions to childhood pertussiscontaining combination vaccines. A nodule may be palpable at the injection site and persist for several weeks. Pertussis Immunization: Common and local adverse events Redness, swelling and pain at the injection site are the most common adverse reactions* to childhood pertussiscontaining combination vaccines. A nodule may be palpable at the injection site and persist for several weeks. The presence of a large injection site reaction to a previous dose is not a contraindication to continuing the recommended schedule. *swelling (greater than 5 cm) and erythema after the 4 th or 5 th doses of DTaP vaccines 15 % to 20% of vaccinees Extensive limb swelling (>10 cm in diameter) possibly involving the entire proximal limb may occur in 2% to 6% of children. 5
6 Conditions NOT Precautions for Tdap Following a dose of DTaP/DTP: temperature 105oF (40.5oC) or higher collapse or shock like state persistent crying lasting 3 hours or longer convulsions with or without fever history of an extensive limb swelling reaction Stable neurologic disorder Pregnancy Breastfeeding Immunosuppression including HIV infection Concurrent minor illness Antimicrobial use Summary Think about it, or you will miss it Treatment can decrease infectivity Immunize! Thanks 6
Diphtheria, Tetanus, and Pertussis. DTaP/DT and Tdap/Td Vaccines
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Diphtheria, Tetanus, and Pertussis DTaP/DT and Tdap/Td Vaccines Jean C. Smith, MD, MPH Medical Officer
More informationFACTS ABOUT PERTUSSIS (WHOOPING COUGH)
FACTS ABOUT PERTUSSIS (WHOOPING COUGH) General Questions About Pertussis What is pertussis? Pertussis, or whooping cough, is a contagious illness that is spread when an infected person sneezes or coughs
More informationPertussis. Information for Physicians. Disease Information. Diagnostic Testing of Suspect Cases. Infectious Disease Epidemiology Program
September 2007 Pertussis Disease Information Incubation Period: 7-10 days; rarely up to 21 days Infectious Period: From prodrome (early symptom) onset to 3 weeks after cough onset. Patients are considered
More informationCorynebacterium diphtheriae
Corynebacterium diphtheriae Aerobic gram-positive bacillus Toxin production occurs only when C. diphtheriae infected by virus (phage) carrying tox gene If isolated, must be distinguished from normal diphtheroid
More information9/11/2018. Tdap/Td Vaccines. Why Adolescents and Adults Need Pertussis Vaccine. Pertussis Complications Among Adolescents and Adults
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Tdap/Td Vaccines September 2018 Chapters 7, 21 and 16 Photographs and images included in this presentation
More informationDiphtheria-Tetanus-Acellular Pertussis-Polio- Combined Vaccine Biological Page (DTaP-IPV)
Diphtheria-Tetanus-Acellular Pertussis-Polio- Combined Vaccine Biological Page (DTaP-IPV) Section 7: Biological Product Information Standard #: 07.212 Created by: Province-wide Immunization Program Standards
More informationer of Cas ses Numb Mid 1940s: Whole cell pertussis vaccine developed *2010 YTD 2008: Tdap pphase- in for grades 6-12 started
Pertussis Update Stephanie Schauer, PhD Epidemiologist Wisconsin Immunization Program November 16, 2010 Pertussis Caused by bacterium Bordetella pertussis Highly communicable, with secondary attack rate
More informationPertussis Pertussis Bordetella pertussis Pathogenesis Clinical Features
Pertussis Pertussis, or whooping cough, is an acute infectious disease caused by the bacterium Bordetella pertussis. Outbreaks of pertussis were first described in the 16th century, and the organism was
More informationObjectives. Immunity. Childhood Immunization Risk of Non-Vaccinated Children 12/22/2015
Childhood Immunization Risk of Non-Vaccinated Children Bertha P. Rojas, Pharm.D. PGY-1 Pharmacy Resident South Miami Hospital Objectives Understand the definition of herd immunity Identify vaccine-preventable
More informationDiphtheria-Tetanus-Acellular Pertussis-Polio- Haemophilus influenzae type b Conjugate Combined Vaccine Biological Page (DTaP-IPV-Hib)
Diphtheria-Tetanus-Acellular Pertussis-Polio- Haemophilus influenzae type b Conjugate Combined Vaccine Biological Page (DTaP-IPV-Hib) Section 7: Biological Product Information Standard #: 07.211 Created
More informationEDUCATIONAL COMMENTARY PERTUSSIS
EDUCATIONAL COMMENTARY PERTUSSIS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn CE Credits
More informationPertussis immunisation for pregnant women
Pertussis immunisation for pregnant women Introduction The routine childhood immunisation programme has been very effective in reducing the overall numbers of cases of pertussis. Before the introduction
More informationTable of Contents. 1.0 INFANRIX hexa VACCINE...3
Table of Contents 1.0 INFANRIX hexa VACCINE...3 1.1 What is INFANRIX hexa vaccine?...3 1.2 When will INFANRIX hexa be introduced?...3 1.3 What is the difference between INFANRIX hexa and Pediacel?...3
More informationBOOSTRIX -POLIO: Diphtheria-Tetanus- Acellular Pertussis-Polio Combined Vaccine Biological Page (dtap-ipv)
BOOSTRIX -POLIO: Diphtheria-Tetanus- Acellular Pertussis-Polio Combined Vaccine Biological Page (dtap-ipv) Section 7: Biological Product Information Standard #: 07.213 Created by: Province-wide Immunization
More informationTEMPORARY PROGRAMME PERTUSSIS VACCINATION FOR PREGNANT WOMEN
TEMPORARY PROGRAMME PERTUSSIS VACCINATION FOR PREGNANT WOMEN Richard Smithson Neil Irvine Maureen McCartney Consultant Health Protection October 2012 Pertussis/whooping cough The disease Whooping Cough
More informationPertussis Pertussis Bordetella pertussis Pathogenesis Clinical Features incubation period
Pertussis Pertussis, or whooping cough, is an acute infectious disease caused by the bacterium Bordetella pertussis. Outbreaks of pertussis were first described in the 16th century, and the organism was
More informationVaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for midwives. August 2014
Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for midwives August 2014 Quality Education for a Healthier Scotland 1 Key Message There is a lot
More information2013 About Pertussis (Whooping Cough)
2013 About Pertussis (Whooping Cough) Pertussis Pertussis, also known as whooping cough, is a highly contagious and often serious disease, especially in young children. 1,2 In adolescents and adults it
More informationCHAMPIONS for LUNG Health. Learn About Pertussis PERTUSSIS
CHAMPIONS for LUNG Health PERTUSSIS Learn About Pertussis Pertussis, also known as whooping cough, is an extremely contagious respiratory infection caused by Bordetella pertussis bacteria. It can be especially
More informationUse of Infanrix -IPV+Hib in the infant primary immunisation schedule
Use of Infanrix -IPV+Hib in the infant primary immunisation schedule An update for registered healthcare practitioners July 2014 Quality Education for a Healthier Scotland 1 Acknowledgments Many thanks
More informationPertussis Testing and Treatment Guidelines
Chicago Department of Public Health City of Chicago Rahm Emanuel, Mayor Pertussis Testing and Treatment Guidelines Date: August 1, 2012 To: Immunization Program Chicago Department of Public Health Bechara
More informationObjectives 3/3/2017. Disease Reporting in Georgia: The School Nurse s Role. Georgia Department of Public Health
Disease Reporting in Georgia: The School Nurse s Role Presentation to: Georgia s School Nurses Presented by: Ebony S. Thomas, MPH Date: Friday, March 10, 2017 Objectives Describe the school nurse s role
More informationWhy every baby should be protected from pertussis (whooping cough)
Why every baby should be protected from pertussis (whooping cough) Infants and young children are at the highest risk for developing severe pertussis. 1 Pertussis, also known as whooping cough, is on the
More informationPertussis: Clinical Review and Colorado s Epidemic
Pertussis: Clinical Review and Colorado s Epidemic Today s Speakers: Robert Brayden, MD, Professor of Pediatrics, University of Colorado School of Medicine, Children s Hospital Colorado Lisa Miller, MD,
More informationPertussis. (Whole-cell pertussis vaccines) must not be frozen, but stored at 2 8 C. All wp vaccines have an expiry date of months.
Program Management 61_5 The wp vaccines have a considerably lower price than ap vaccines and, where resources are limited and the vaccine is well accepted by the local population, wp vaccine remains the
More informationPrince Edward Island Guidelines for the Management and Control of Pertussis
Prince Edward Island Guidelines for the Management and Control of Pertussis November 2015 Table of Contents 1. General Guidelines... 2 1.1 Clinical Presentation... 3 1.2 Epidemiology... 4 2. Diagnosis...
More informationWhat all moms should know about protecting themselves and their children against pertussis CALLING ALL NEW MOMS
What all moms should know about protecting themselves and their children against pertussis CALLING ALL NEW MOMS CALLING ALL NEW MOMS Pertussis a serious disease that every parent and person in close contact
More informationAddressing an Epidemic: The Clinicians Role in Preventing Pertussis
Welcome! Addressing an Epidemic: The Clinicians Role in Preventing Pertussis Mark Sawyer, MD. FAAP Presented by: California Department of Public Health Co-sponsor: California Immunization Coalition Joint
More information1. QUALITATIVE AND QUANTITATIVE COMPOSITION
INFANRIX 1. QUALITATIVE AND QUANTITATIVE COMPOSITION contains diphtheria toxoid, tetanus toxoid, and three purified pertussis antigens [pertussis toxoid (PT), filamentous haemagglutinin (FHA) and 69 kilodalton
More informationSurveillance, Reporting and Control of Influenza and Pertussis. Steve Fleming, EdM Hillary Johnson, MHS Epidemiologists Immunization Program, MDPH
Surveillance, Reporting and Control of Influenza and Pertussis Steve Fleming, EdM Hillary Johnson, MHS Epidemiologists Immunization Program, MDPH Disclosures The speaker has no financial interest or conflict
More informationSummary of Key Points
Summary of Key Points WHO Position Paper on Vaccines against Pertussis September 2015 1 Background l Pertussis (whooping cough), caused by the bacterium Bordetella pertussis, was one of the most common
More informationVaccination against pertussis(whooping cough)
Vaccination against pertussis(whooping cough) Vaccination now recommended from 16 weeks of pregnancy An update for registered healthcare practitioners February 2018 additions and/or revisions of any kind
More informationRecommended Vaccinations for Patients with Chronic Lung Disease RORY JOHNSON, PHARM.D., AE C ASSISTANT PROFESSOR UNIVERSITY OF MONTANA
Recommended Vaccinations for Patients with Chronic Lung Disease RORY JOHNSON, PHARM.D., AE C ASSISTANT PROFESSOR UNIVERSITY OF MONTANA Disclosures Nothing to Disclose Learning Objectives At the conclusion
More informationPertussis. Gary Reubenson 10 September 2014
Pertussis Gary Reubenson 10 September 2014 Conflicts of Interest Sanofi Local Conference support Study sponsor Pfizer Local & International Conference Support Speakers fee Abbvie Speakers fee Overview
More informationCLINICAL PHARMACOLOGY INFANRIX DTPa vaccine, induces antibodies against all vaccine components.
INFANRIX PRODUCT INFORMATION NAME OF THE MEDICINE Diphtheria-tetanus-acellular pertussis (DTPa) vaccine DESCRIPTION INFANRIX DTPa vaccine is a sterile suspension which contains diphtheria toxoid, tetanus
More informationGet Up-to-Date. With Tdap. You can make a difference. Increase Tdap vaccination rates among your adolescent and adult patients
You can make a difference Get Up-to-Date Increase Tdap vaccination rates among your adolescent and adult patients With Tdap Tetanus, diphtheria, and acellular pertussis counseling guide Identify: Proactively
More informationHealth Professionals Advice: Summer
Health Professionals Advice: Summer 2013-2014 SITUATION UPDATE The Pertussis epidemic which began in May 2011 has continued all year, without any sign of abating. Between 1 January and 10 December 2013
More informationHEALTH PROFESSIONAL ADVICE: Pertussis (update March 2014)
5 March 2014 HEALTH PROFESSIONAL ADVICE: Pertussis (update March 2014) SITUATION UPDATE The Pertussis epidemic which began in May 2011 has continued without any sign of abating. In 2013 there were 791
More informationPolio Vaccine Biological Page
Polio Vaccine Biological Page Section 7: Biological Product Information Standard #: 07.300 Created by: Approved by: Province-wide Immunization Program Standards and Quality Province-wide Immunization Program,
More information7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids
7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids Contents Introduction Nunavut Recommended Childhood Immunization Schedule Nunavut Routine Adult Immunization Schedule Nunavut Immunization
More informationVaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for midwives
Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for midwives August 2014 Quality Education for a Healthier Scotland 1 Background As you will be
More informationSAMPLE. PGD reviewed by: Dr Tim Patterson, Chris Faldon, John Maloney, Adrian Mackenzie
Patient Group Direction for the Supply or Administration of combined Diphtheria, Tetanus, acellular Pertussis, inactivated Polio vaccine and Haemophilus type b conjugate Vaccine (Infanrix-IPV-HIB) to children
More informationC o l o r a d o I m m u n i z a t i o n M a n u a l S E C T I O N 8 Vaccines
S E C T I O N 8 Vaccines 8. Vaccines I S S U E D : 9 / 1 / 9 8 R E V I S E D : 5 / 1 / 1 1 S E C T I O N - P A G E : 8-1 S U B J E C T : C O N T E N T S CONTENTS S E C T I O N 8 Vaccines DTaP...............................................
More informationIt s all about the Whoop
It s all about the Whoop Pertussis On Campus By Rebecca DiSaia Minus, MSN, RN, CNL Hear what Whooping cough sounds like Stages of Pertussis Catarrhal Stage Paroxysmal Stage Convalescent Stage (Recovery)
More informationCoughing up the Facts on Pertussis Emerging Trends and Communication Efforts
Coughing up the Facts on Pertussis Emerging Trends and Communication Efforts Alison Patti, MPH, CHES National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention
More informationFrequently Asked Questions Pertussis (Whooping Cough) in the School Setting
Frequently Asked Questions Pertussis (Whooping Cough) in the School Setting General information What is pertussis? Who can get pertussis? What are the symptoms of pertussis? How soon do symptoms of pertussis
More informationPEDIACEL. Intramuscular injection. Suspension for injection. DESCRIPTION
PEDIACEL Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine and Haemophilus b Conjugate Vaccine (Tetanus Protein - Conjugate) Intramuscular
More informationUsing the EMR to Improve Tdap Vaccination Rates in Pregnant Women
Using the EMR to Improve Tdap Vaccination Rates in Pregnant Women Webinar Guidelines 1 hour presentation including a Q&A discussion period at the end. Send your questions at any time during the presentation
More informationUpdated WHO position paper on pertussis vaccines. Geneva, Switzerland October 2010
Updated WHO position paper on pertussis vaccines Geneva, Switzerland October 2010 Introduction Replaces the position paper on pertussis vaccines published in the Weekly Epidemiological Record in January
More informationVaccine Information Statement: PEDIATRIC VACCINES (Multiple)
Vaccine Information Statement: PEDIATRIC VACCINES (Multiple) 1. Your Baby s First Vaccines: What You Need to Know Babies get six vaccines between birth and 6 months of age. These vaccines protect your
More informationHealth Professionals Advice: Pertussis 7 June, 2012
Health Professionals Advice: Pertussis 7 June, 2012 SITUATION UPDATE Since 1 January 2012 there have been 322 cases of pertussis notified and over 1,500 contacts requiring follow up. Of concern, two recent
More informationMandates and More. Julie Morita, M.D. Deputy Commissioner Chicago Department of Public Health. Chicago Department of Public Health
Mandates and More Julie Morita, M.D. Deputy Chicago Department of Public Health Why are vaccines required for school entry? School Vaccine Requirements Small pox vaccine required in Massachusetts 1855
More informationPertussis Toolkit for Schools
Pertussis Toolkit for Schools Burlington County Health Department December 2012 1 CONTENTS What to do if you suspect a case of pertussis in your school 3 Pertussis reporting form 5 Pertussis Fact sheet
More informationBOOSTRIX. Combined diphtheria, tetanus, acellular pertussis vaccine
BOOSTRIX Combined diphtheria, tetanus, acellular pertussis vaccine QUALITATIVE AND QUANTITATIVE COMPOSITION 1 dose (0.5 ml) contains: Diphtheria toxoid 1 Tetanus toxoid 1 Bordetella pertussis antigens
More informationPERTUSSIS The Unpredictable Burden of Disease. Lawrence D. Frenkel, MD, FAAP AAP/Novartis Grand Rounds Webinar February 7, 2013
PERTUSSIS The Unpredictable Burden of Disease Lawrence D. Frenkel, MD, FAAP AAP/Novartis Grand Rounds Webinar February 7, 2013 Pertussis Agent Bordetella pertussis Nonmotile, fastidious, gram-negative,
More informationBoostrix polio. 3. PHARMACEUTICAL FORM Suspension for injection. 4. CLINICAL PARTICULARS
Boostrix polio 1. NAME OF THE MEDICINAL PRODUCT boostrix polio Combined diphtheria, tetanus, acellular pertussis and enhanced inactivated polio vaccine. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION boostrix
More informationPAEDIATRIC ACUTE CARE GUIDELINE. Pertussis. This document should be read in conjunction with this DISCLAIMER
Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Pertussis Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should be read in conjunction
More informationBOOSTRIX QUALITATIVE AND QUANTITATIVE COMPOSITION PHARMACEUTICAL FORM CLINICAL PARTICULARS. Indications. Dosage and Administration
BOOSTRIX Diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed, reduced antigen(s) content) QUALITATIVE AND QUANTITATIVE COMPOSITION 1 dose (0.5 ml) contains: Diphtheria toxoid 1 Tetanus
More informationPERTUSSIS, OR WHOOPING COUGH, IS AN ACUTE INFECTIOUS
6 Chapter Per ertussis PERTUSSIS, OR WHOOPING COUGH, IS AN ACUTE INFECTIOUS disease caused by the bacterium Bordetella pertussis. Outbreaks of pertussis were first described in the 16th century, and the
More informationPreschool Asthma What you need to know in 10 minutes
Preschool Asthma What you need to know in 10 minutes Alan Kaplan MD CCFP(EM) FCFP Family Physician Airways Group of Canada Respiratory Medicine section CFPC Faculty/Presenter Disclosure Faculty: Alan Kaplan
More informationCHILDHOOD VACCINATION
EPI (3) Age of Child How and Where is it given? CHILDHOOD VACCINATION Nicolette du Plessis Block 10 28/02/2012 10 weeks DTaP-IPV/Hib (2) Diphtheria, Tetanus, Acellular pertussis, Inactivated polio vaccine,
More informationPedro Plans-Rubió 1,4 Encarna Navas. Angela Domínguez 3,4 Mireia Jané
PharmacoEconomics Open https://doi.org/10.1007/s41669-018-0081-4 ORIGINAL RESEARCH ARTICLE Reduction of Direct Health Costs Associated with Pertussis Vaccination with Acellular Vaccines in Children Aged
More informationTETANUS, DIPHTHERIA, PERTUSSIS (Td/Tdap)
TETANUS, DIPHTHERIA, PERTUSSIS (Td/Tdap) WHAT YOU NEED TO KNOW ARE YOU SURE YOU USE THE RIGHT MEASURES TO PROTECT YOURSELF AGAINST TETANUS, DIPHTHERIA OR PERTUSSIS? GET INFORMED! GET VACCINATED! GET PROTECTED!
More informationCombined diphtheria-tetanus-acellular pertussis (dtpa) and Inactivated Poliovirus Vaccine
Combined diphtheria-tetanus-acellular pertussis (dtpa) and Inactivated Poliovirus Vaccine Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you start using
More informationVaccination against pertussis (whooping cough) an update for registered healthcare practitioners Questions and Answers
Vaccination against pertussis (whooping cough) an update for registered healthcare practitioners Questions and Answers April 2016 Health Protection Scotland is a division of NHS National Services Scotland.
More informationA. Children born in 1942 B. Children born in 1982 C. Children born in 2000 D. Children born in 2010
Who do you think received the most immunologic components in vaccines? Development of which vaccine slowed after the invention of antibiotics? A. Children born in 1942 B. Children born in 1982 C. Children
More informationSuspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular component) vaccine (adsorbed, reduced antigen content)
Package leaflet: Information for the user TdaPBooster Suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular component) vaccine (adsorbed, reduced antigen content)
More informationTETANUS, DIPHTHERIA, WHOOPING COUGH (Td/Tdap)
TETANUS, DIPHTHERIA, WHOOPING COUGH (Td/Tdap) WHAT YOU NEED TO KNOW ARE YOU SURE YOU USE THE RIGHT MEASURES TO PROTECT YOURSELF AGAINST TETANUS, DIPHTHERIA OR PERTUSSIS? GET INFORMED! GET VACCINATED! GET
More informationA Parent s Guide to Childhood Immunization. Be informed.
A Parent s Guide to Childhood Immunization Be informed. Table of Contents Immunization: our best defense... 1 How vaccines work... 2 Vaccine-preventable diseases... 3 Effect of immunization on vaccine-preventable
More informationWhooping cough vaccine for pregnant women
Whooping cough vaccine for pregnant women What is whooping cough (pertussis)? Whooping cough (also known as pertussis) is a highly contagious illness that can be life threatening. The disease is most serious
More informationInfanrix TM Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa) vaccine
Infanrix TM Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa) vaccine QUALITATIVE AND QUANTITATIVE COMPOSITION Infanrix TM contains diphtheria toxoid, tetanus toxoid and three purified
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Boostrix, Suspension for injection in pre-filled syringe Diphtheria, tetanus, and pertussis (acellular, component) vaccine (adsorbed, reduced antigen(s) content)
More informationImmunizations for Health Care Workers
Immunizations for Health Care Workers Tanisha Taylor, MD, MPH Senior Medical Director Barnabas Health Corporate Care Tanisha Taylor MD, MPH Senior Medical Director Barnabas Health Corporate Care CDC Immunizations
More informationNew Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines
New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines Antigens Vaccine Approved Age Daptacel Diphtheria, Tetanus, and acellular Pertussis (DTaP)
More informationSUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) I.P. Injectable, Suspension for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 0.5 ml contains:
More informationConsiderations for Public Health on Pertussis Case and Contact Management
Considerations for Public Health on Pertussis Case and Contact Management September 2015 History of Pertussis and Immunization Pertussis outbreaks tend to be cyclical in nature, with increased disease
More informationQuadracel. Copyright , MIMS Australia Page 1 of 5
Quadracel MIMS Abbreviated Prescribing Information Diphtheria toxoid; pertussis vaccine; poliomyelitis vaccine; tetanus toxoid Sanofi Pasteur Section: 10(a) Vaccines - Immunology Use in pregnancy: B2 Permitted
More informationGrade 8 Immunization Package
Grade 8 Immunization Package Tetanus, Diphtheria, Pertussis Vaccine Vaccines have saved more lives in Canada in the last 60 years than any other medical intervention. Vaccines help your immune system to
More informationImmunization Update: New CDC Recommendations. Blaise L. Congeni M.D. 2012
Immunization Update: New CDC Recommendations Blaise L. Congeni M.D. 2012 Polysaccharide Vaccines Vaccine Hib capsule polysaccharide PRP (polyribose ribitol phosphate) Not protective in infants
More informationPERTUSSIS. Introduction
PERTUSSIS Introduction Pertussis (whooping cough) is a highly contagious acute respiratory tract infection caused by the bacterium Bordetella pertussis. It is spread by aerosol droplets. Neither vaccination
More informationPertussis: An Emerging Infection. Holly K. Ehrke. Ferris State University
Running head: PERTUSSIS AN EMERGING INFECTION 1 Pertussis: An Emerging Infection Holly K. Ehrke Ferris State University PERTUSSIS AN EMERGING INFECTION 2 Abstract Pertussis is a highly contagious disease
More informationAUSTRALIAN PRODUCT INFORMATION
AUSTRALIAN PRODUCT INFORMATION NAME OF THE MEDICINE ADACEL Pertussis Vaccine-Acellular Combined with Diphtheria and Tetanus Toxoids (Adsorbed) DESCRIPTION ADACEL is a sterile, uniform, cloudy, white suspension
More informationProtecting the Innocent Bystander The Importance of Vaccination During Pregnancy
Disclosures Protecting the Innocent Bystander The Importance of Vaccination During Pregnancy Judy Guzman-Cottrill, DO Professor of Pediatrics Division of Infectious Diseases Oregon Health & Science University
More informationImmunization Manual Pre-Departure Medical Services Interim Federal Health Program
Immunization Manual Pre-Departure Medical Services Interim Federal Health Program Background The Pre-departure Medical Services (PDMS) under the Interim Federal Health Program (IFHP) will be effective
More informationCalifornia 2010 Pertussis Epidemic. Kathleen Winter, MPH Immunization Branch California Department of Public Health
California 2010 Pertussis Epidemic Kathleen Winter, MPH Immunization Branch California Department of Public Health Overview Pertussis Background California Pertussis Epidemic Challenges and Success Ongoing
More informationINFANRIX -penta Datasheet
INFANRIX -penta Datasheet NAME OF THE MEDICINE INFANRIX -penta Combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated polio vaccine. QUALITATIVE AND QUANTITATIVE COMPOSITION INFANRIX
More informationPertussis: Trends, Prevention and Challenges Flor M. Munoz, MD Associate Professor Pediatric Infectious Diseases
Pertussis: Trends, Prevention and Challenges Flor M. Munoz, MD Associate Professor Pediatric Infectious Diseases Disclosure I do not have any relevant conflicts of interest to disclose. Page 1 xxx00.#####.ppt
More informationFor the use only of Registered Medical Practitioners or a Hospital or a Laboratory
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory INFANRIX Diphtheria Tetanus and Pertussis (Acellular Component) Vaccine (Adsorbed) Ph. Eur. 1. NAME OF THE MEDICINAL PRODUCT
More informationVaccine Preventable Diseases. Overview MEASLES 4/8/2015. Amy Schwartz, MPH Immunization Surveillance Coordinator North Dakota Department of Health
Vaccine Preventable Diseases Amy Schwartz, MPH Immunization Surveillance Coordinator North Dakota Department of Health Measles Mumps Pertussis Meningococcal Disease Polio Rubella Hepatitis A Overview MEASLES
More information2017 Vaccine Preventable Disease Summary
2017 Vaccine Preventable Disease Summary Prepared 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata October 2018 2017 Summary of Vaccine Preventable Diseases in Ottawa County This is a detailed
More informationSee 17 for PATIENT COUNSELING INFORMATION. Revised: 10/2016
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BOOSTRIX safely and effectively. See full prescribing information for BOOSTRIX. BOOSTRIX (Tetanus
More informationHelp protect your child. At-a-glance guide to childhood vaccines.
Help protect your child. At-a-glance guide to childhood vaccines. 40976_CDCupdate.indd 1 Why vaccines matter. Thanks to widespread vaccination programs, several diseases that can infect our children have
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Tetravac, suspension for injection Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine, adsorbed. Read all of this leaflet
More informationFor the use only of Registered Medical Practitioners or a Hospital or a Laboratory HIBERIX
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory HIBERIX Haemophilus type b conjugated vaccine IP 1. NAME OF THE MEDICINAL PRODUCT Haemophilus type b conjugated vaccine
More informationPatient Immunization FAQ Sheet
Patient Immunization FAQ Sheet Shingles Vaccine: Q: Who should get the shingles vaccine (Zostavax )? A: Anyone 60 years of age or should get the shingles (herpes zoster) vaccine. There is no maximum age
More informationWhat DO the childhood immunization footnotes reveal? Questions and answers
What DO the childhood immunization footnotes reveal? Questions and answers Stanley E. Grogg, DO, FACOP, FAAP he Advisory Committee on Immunization Practices (ACIP) recommends the childhood vaccination
More informationBOOSTRIX -IPV PRODUCT INFORMATION. BOOSTRIX-IPV is a combined diphtheria, tetanus, acellular pertussis (dtpa) and inactivated poliovirus vaccine.
BOOSTRIX -IPV PRODUCT INFORMATION NAME OF THE MEDICINE BOOSTRIX-IPV is a combined diphtheria, tetanus, acellular pertussis (dtpa) and inactivated poliovirus vaccine. DESCRIPTION BOOSTRIX-IPV is a sterile
More informationCase Presentation: Pertussis: The Resurgence of an Old Disease. Case Presentation: Case Presentation: Case Presentation: Case Presentation:
Pertussis: The Resurgence of an Old Disease Controlling an Outbreak in Your Community You have finally finished your training! As a new healthcare provider, you are working in a Family Medicine office.
More informationWhat are the new active vaccine recommendations in the Canadian Immunization Guide?
154 CCDR 17 April 2014 Volume 40-8 https://doi.org/10.14745/ccdr.v40i08a03 1 What are the new active vaccine recommendations in the Canadian Immunization Guide? Warshawsky B 1 and Gemmill I 2 on behalf
More informationANNEX I ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Infanrix hexa, Powder and suspension for suspension for injection. Diphtheria, tetanus, acellular pertussis, hepatitis
More information